Cancer Vaccines
Studies from University of Manchester yield new information about cancer vaccines
Published in Vaccine Weekly, June 25th, 2008
" The human 5T4 ( h5T4) oncofoetal antigen is expressed by a wide variety of human carcinomas including colorectal, ovarian, gastric and renal, but rarely on normal tissues. Its restricted expression on tumour tissues as well as its association with tumour progression and bad prognosis has driven the development of a MVA-based vaccine (TroVax) which has been tested in several early phase clinical trials and these studies have led to the start of a phase III trial in renal cell carcinoma patients," scientists writing in the journal Cancer Immunology Immunotherapy report.
"We have recently shown that CD8(+) T cells recognizing h5T4 can be generated in the absence...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-06-25)
More Articles from Vaccine Weekly
- Cure Lab, Inc.
A protein sequence associated with Huntington's disease may become life-saving vaccine component - Society for General Microbiology
New pathogen from pigs' stomach ulcers - University of South Florida Health
Protein plays key role in transmitting deadly malaria parasite - DNA Vaccines
Research on DNA vaccines described by Y. Chen and colleagues - DNA Vaccines
Studies from University of Queensland yield new data on DNA vaccines - Helicobacter pylori
Investigators at University of Michigan target helicobacter pylori - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
